Reaction Details Report a problem with these data
Target
GTPase KRas [G12C]
Ligand
BDBM591767
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
550±n/a nM
Citation
 Koltun, ES; Cregg, J; Gill, AL; Buckl, A; Liu, Y Ras inhibitors US Patent  US11566007 Publication Date 1/31/2023 
Target
Name:
GTPase KRas [G12C]
Synonyms:
GTPase KRas (G12C) | KRAS | KRAS2 | RASK2 | RASK_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
21702.19
Organism:
Homo sapiens (Human)
Description:
P01116[G12C]
Residue:
189
Sequence:
MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM
  
Inhibitor
Name:
BDBM591767
Synonyms:
US11566007, Example A447
Type:
Small organic molecule
Emp. Form.:
C47H61N9O8
Mol. Mass.:
880.0427
SMILES:
CCn1c(c2CC(C)(C)COC(=O)[C@@H]3CCCN(N3)C(=O)[C@H](Cc3nnc(o3)-c3ccc1c2c3)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H]1CCN(C1)C(=O)C=C)-c1cccnc1[C@H](C)OC |r,wU:21.38,60.67,37.45,wD:13.18,45.49,(-9.42,-6.95,;-7.93,-6.55,;-7.53,-5.07,;-8.44,-3.82,;-7.53,-2.58,;-7.53,-1.04,;-6.2,-.27,;-4.71,.13,;-5.11,-1.35,;-6.05,1.56,;-4.72,2.33,;-4.72,3.87,;-6.05,4.64,;-3.39,4.64,;-3.39,6.18,;-2.05,6.95,;-.72,6.18,;-.72,4.64,;-2.05,3.87,;.61,3.87,;1.95,4.64,;.61,2.33,;-.72,1.56,;-.72,.02,;.61,-.75,;.61,-2.29,;-2.05,-2.29,;-2.05,-.75,;-3.4,-3.05,;-3.4,-4.59,;-4.73,-5.36,;-6.07,-4.59,;-6.07,-3.05,;-4.73,-2.28,;1.95,1.56,;3.28,2.33,;3.28,3.87,;4.62,1.56,;4.62,.02,;5.95,-.75,;3.28,-.75,;5.95,2.33,;5.95,3.87,;7.28,1.56,;7.28,.02,;8.62,2.33,;10.08,1.86,;10.99,3.1,;10.08,4.35,;8.62,3.87,;10.48,5.84,;9.39,6.93,;11.97,6.24,;13.06,5.15,;-9.98,-3.82,;-10.75,-5.15,;-12.29,-5.15,;-13.06,-3.82,;-12.29,-2.49,;-10.75,-2.49,;-9.98,-1.15,;-8.44,-1.15,;-10.75,.18,;-9.98,1.51,)|
Structure:
Search PDB for entries with ligand similarity: